MSD rotavirus vaccine approved to launch market
The KFDA approved Rotateq for the prevention of infant's viral infections in the gastrointestinal tracts by G1, G2, G3, G4, G9PIA (8) types of rotavirus.
The market distribution of Rotateq and customers services will be responsible by SK Chemical according to the strategic alliance betwee...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
